Neurocrine Bioscience buy UBS Group AG
Start price
04.04.25
/
50%
€86.72
Target price
04.04.26
€123.79
Performance (%)
50.08%
Price
12.12.25
€130.15
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Neurocrine Bioscience has seen massive gains of 50.08%. This prediction currently runs until 04.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by UBS_Group_AG for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at UBS Group AG from $154.00 to $137.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.80
09.10.25
09.10.25
€167.52
09.10.26
09.10.26
8.64%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.95
09.07.25
09.07.25
€148.44
09.07.26
09.07.26
14.22%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€134.58
06.05.26
06.05.26
20.34%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
08.01.25
08.01.25
€157.20
08.01.26
08.01.26
-3.59%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.45
28.05.24
28.05.24
€177.37
28.05.25
28.05.25
-13.52%
29.05.25
29.05.25